NIH lab study finds 13 antibodies that target molecules linked to tick-related red-meat allergy
No specific alpha-gal treatment exists today beyond managing reactions. Lab antibodies are an early research step, not a proven human therapy. Talk with a doctor about symptoms.
Alpha-gal syndrome is an allergy to red meat and other mammal products — such as from cows, pigs and lambs — that can follow certain tick bites, NIH News in Health says in its November 2026 feature. Some ticks carry a sugar called alpha-gal in their saliva; later meals with alpha-gal can trigger reactions from stomach trouble to life-threatening responses.
Why it matters: NIH notes ticks cause hundreds of thousands of new U.S. illnesses each year, and bites can leave people with this food allergy. There is no specific treatment for alpha-gal syndrome today — only care for allergic reactions — so people must avoid tick bites and the foods that trigger a response.
Lab tests found 13 human monoclonal antibodies that targeted molecules linked to those allergic responses, NIH says, summarizing a September 2026 Journal of Clinical Investigation paper funded by NIH's Intramural Research Program and NIAID. Implication: the work is an early step toward possible prevention or targeted therapies, but the antibodies have not been proven to prevent or treat the syndrome in people; more research is needed. Dr. John Powers, acting NIAID director, called it "the first step in potentially identifying ways to prevent AGS and develop new targeted therapies." This is not medical advice; talk with a doctor about symptoms or testing.
Source: NIH News in Health: Finding Treatments for Tick-Related Red Meat Allergy (November 2026), checked Nov. 6, 2026.